Literature DB >> 222591

Adenylate kinase activity and glutathione concentration of cerebrospinal fluid in different neurological disorders.

G Ronquist, G Frithz.   

Abstract

Adenylate kinase activity and glutathione concentration were measured in cerebrospinal fluid (CSF) of 64 consecutive patients admitted for various neurological disorders. These two analyses were performed in addition to conventional examination of the CSF. Neurological symptoms most probably connected in some cases with no and in others with only subtle changes in the central nervous system were linked to no or only moderate activities of adenylate kinase together with no glutathione. 1 patient with meningioma had no adenylate kinase activity at all while 3 patients with malignant brain tumours showed clear activities similar to 3 patients with well established diagnoses of multiple sclerosis. On the contrary, glutathione was absent in CSF of the patients with brain tumours and multiple sclerosis. Various cerebrovascular diseases involving larger areas of the brain tissue resulted in clear adenylate kinase activities in CSF either alone as in 11 of the patients with cerebral infarction or in combination with the appearance of also glutathione as in the remaining 7 patients with cerebral infarction as well as in the 14 patients studied with hemorrhages of the brain.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 222591     DOI: 10.1159/000115063

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  3 in total

1.  Drug action on adenylate kinase activity in cerebrospinal fluid of arteriosclerotic patients.

Authors:  G Frithz; G Ronquist; B Andersson
Journal:  Experientia       Date:  1980-12-15

2.  CSF cyclic AMP and CSF adenylate kinase in cerebral ischaemic infarction.

Authors:  T Büttner; C R Hornig; O Busse; W Dorndorf
Journal:  J Neurol       Date:  1986-10       Impact factor: 4.849

3.  Studies of biochemical markers in cerebrospinal fluid in patients with meningoencephalitis.

Authors:  G Ronquist; T Callerud; F Niklasson; G Friman
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.